CADTH has convened a pan-Canadian Advisory Panel on a Framework for a Prescription Drug List (the Panel). The Panel will provide recommendations on developing a potential pan-Canadian prescription drug list (or formulary). Stakeholder consultations are scheduled to take place in the fall and winter of 2021, leading to a final public report setting out the Panel’s non-binding recommendations in April 2022.
Mandate and membership of the Panel
According to CADTH, the Panel’s recommendations are intended to contribute to discussions on a potential pan-Canadian prescription drug list. The mandate of the Panel is to:
- Recommend principles and a framework for